First-of-its-Kind Defibrillator Offers Protection with Less Risk to the Heart
By Mel Fabrikant Tuesday, January 29, 2013, 10:47 AM EST
The Valley Hospital is the first hospital in northern New Jersey, and one of only three hospitals in the tri-state area, to implant the S-ICD®, a revolutionary implantable cardioverter-defibrillator (ICD) for patients deemed at high risk for sudden death due to a heart rhythm disorder (arrhythmia). This leading-edge technology allows the ICD to be placed under the skin, rather than in blood vessels, and does not have an electrode connected directly to the heart.
Electrophysiologists at the Arrhythmia Institute, part of The Valley Hospital's Heart and Vascular Institute, are among a select group nationwide to have first use of the S-ICD®, chosen for their vast experience, expertise, and research in the diagnosis and treatment of arrhythmias. Although ICDs have been available for decades, electrodes from older devices can fail, cause infection, or injure heart muscle and blood vessels. The S-ICD® offers similar benefits as other ICDs, but without an electrode located within the heart. X-ray guidance is not required for implantation and it has been proven to be 100 percent successful in treating severe arrhythmias.
Valley's Arrhythmia Institute provides a full range of the most effective diagnostic tests and treatments for heart rhythm disorders. Advances include robotic ablation procedures, Stereotaxis Niobe technology, pacemakers, ICD technology, and cardiac resynchronization therapy devices.
For more on the advanced cardiology services offered by The Valley Hospital's Heart and Vascular Institute, contact us via e-mail.